
    
      The study is designed to determine the safety and effectiveness for drug coated balloon (DCB)
      for treating intestinal strictures.

      Up to 15 subjects are planned to be enrolled and treated with the study device at up to 5
      clinical sites outside of US. Subjects will be followed up post-treatment to one year and
      then annually for up to 5 years. The annual follow up after the first year is optional.
    
  